Karlqvist S, Sachs MC, Eriksson C, Cao Y, et al. Comparative risk of serious infection with vedolizumab vs anti-TNF in inflammatory bowel disease: results from nationwide Swedish registers. Am J Gastroenterol 2024 Jul 12. doi: 10.14309/ajg.0000000000002961.
PMID: 38994835